Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Vaccines × Other hematologic neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 CNS 1 Breast 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Cytarabine 29 Cyclophosphamide 23 fludarabine phosphate 21 fludarabine 21 Azacitidine 19 Rituximab 16 venetoclax 14 Peripheral Blood Stem Cell Transplantation 13 Methotrexate 13 Dasatinib 11 Bendamustine Hydrochloride 11 Filgrastim 10 Busulfan 10 ibrutinib 9 Whole-Body Irradiation 9 Tacrolimus 8 Radiotherapy 8 Lenalidomide 8 Idarubicin 8 Granulocyte Colony-Stimulating Factor 8 Melphalan 6 Etoposide 6 Dexamethasone 6 Decitabine 6 Daunorubicin 6 Cyclosporine 6 duvelisib 5 acalabrutinib 5 Nivolumab 5 Mycophenolic Acid 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01483274 2017-05-09

AML

University of Louisville

Phase 1 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡